Dr. Adil Ghaffar, MD

Dr. Ghaffar practices at Saint Francis Medical Center in Cape Girardeau, Missouri, part of Saint Francis Healthcare System.

Dr. Ghaffar's NPI, 1124571948, was assigned on July 28, 2016. Dr. Ghaffar holds Missouri license 2020042379.

Dr. Ghaffar's primary practice is Saint Francis Medical Center, at 211 St Francis Dr, Cape Girardeau, MO 63703 in Cape Girardeau County. The practice phone is (573) 331-3000.

Dr. Ghaffar's primary practice is Saint Francis Medical Center in Cape Girardeau, Missouri, part of Saint Francis Healthcare System. Dr. Ghaffar is also affiliated with Mercy Hospital Southeast. The medical group on file is Saint Francis Medical Center. Dmand AI also links Dr. Ghaffar to 2 more dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Ghaffar's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ghaffar practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Ghaffar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Ghaffar is licensed in Missouri.

CMS data shows 1,831 Medicare services from Dr. Ghaffar across 7 procedure codes in 2024, for 387 Medicare patients. Medicare paid $173,859 for them.

CMS counts 387 Medicare patients who saw Dr. Ghaffar in 2024. The largest group is 75 to 84, with 150 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 3.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ghaffar's median patient age at 75, with 50% women.

In 2024, Dr. Ghaffar wrote 2,737 Medicare Part D claims for 292 patients. 83% of them were for generic drugs. CMS names the drug for 2,543 of them, across 37 drugs with 11 or more claims each, at $483,095 in total drug cost. In 2023, CMS named 1,634 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 67 out of 100 for Dr. Ghaffar for performance year 2024, reported through an alternative payment model (APM). Dr. Ghaffar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Ghaffar in 2021. 2021 was the busiest year, with 2. Dr. Ghaffar's most frequent co-authors are Fahad Aziz, MD, Didier A. Mandelbrot, MD and Maha Abdalla Mohamed, MD.

CMS Open Payments shows 37 general payments to Dr. Ghaffar from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Pfizer Inc. paid the most, $165.